PMID- 31391499 OWN - NLM STAT- MEDLINE DCOM- 20201106 LR - 20210110 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 9 IP - 1 DP - 2019 Aug 7 TI - High Glucose Environments Interfere with Bone Marrow-Derived Macrophage Inflammatory Mediator Release, the TLR4 Pathway and Glucose Metabolism. PG - 11447 LID - 10.1038/s41598-019-47836-8 [doi] LID - 11447 AB - Macrophages may be a crucial aspect of diabetic complications associated with the inflammatory response. In this study, we examined how hyperglycaemia, a common aspect of diabetes, modulates bone marrow-derived macrophages (BMDMs) under an inflammatory stimulus. To perform this study, BMDMs from non-diabetic and diabetic (60 mg/kg alloxan, i.v.) male C57BL/6 mice (CEUA/FCF/USP-488) were cultured under normal (5.5 mM) and high glucose (HG, 25 or 40 mM) conditions and stimulated or not stimulated with lipopolysaccharide (LPS, 100 ng/mL). Compared to the BMDMs from the normoglycaemic mice, the LPS-stimulated BMDMs from the diabetic mice presented reduced TLR4 expression on the cell surface, lower phagocytic capacity, and reduced secretion of NO and lactate but greater oxygen consumption and greater phosphorylation of p46 SAPK/JNK, p42 ERK MAPK, pAKT and pPKC-delta. When the BMDMs from the non-diabetic mice were cultured under high-glucose conditions and stimulated with LPS, TLR4 expression was reduced on the cell surface and NO and H(2)O(2) levels were reduced. In contrast, the diabetic BMDMs cultured under high glucose conditions presented increased levels of lactate and reduced phosphorylation of AKT, PKC-delta and p46 SAPK/JNK but enhanced phosphorylation of the p46 subunit of SAPK/JNK after LPS stimulation. High glucose levels appear to modify macrophage behaviour, affecting different aspects of diabetic and healthy BMDMs under the same LPS stimulus. Thus, hyperglycaemia leaves a glucose legacy, altering the basal steady state of macrophages. FAU - Ayala, Thais Soprani AU - Ayala TS AD - Laboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences of University Sao Paulo (FCF/USP), Sao Paulo, Brazil. FAU - Tessaro, Fernando Henrique Galvao AU - Tessaro FHG AUID- ORCID: 0000-0002-0389-5976 AD - Laboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences of University Sao Paulo (FCF/USP), Sao Paulo, Brazil. FAU - Jannuzzi, Grasielle Pereira AU - Jannuzzi GP AD - Laboratory of Cellular Immunology and Biochemistry of Fungus and Protozoa, Department of Pharmaceutical Sciences Analysis, Federal University of Sao Paulo, Sao Paulo, Brazil. FAU - Bella, Leonardo Mendes AU - Bella LM AD - Laboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences of University Sao Paulo (FCF/USP), Sao Paulo, Brazil. FAU - Ferreira, Karen Spadari AU - Ferreira KS AD - Laboratory of Cellular Immunology and Biochemistry of Fungus and Protozoa, Department of Pharmaceutical Sciences Analysis, Federal University of Sao Paulo, Sao Paulo, Brazil. FAU - Martins, Joilson O AU - Martins JO AUID- ORCID: 0000-0003-2630-7038 AD - Laboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences of University Sao Paulo (FCF/USP), Sao Paulo, Brazil. martinsj@usp.br. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190807 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Blood Glucose) RN - 0 (Culture Media) RN - 0 (Inflammation Mediators) RN - 0 (Lipopolysaccharides) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 4) RN - 6SW5YHA5NG (Alloxan) SB - IM MH - Alloxan/toxicity MH - Animals MH - Blood Glucose/immunology/*metabolism MH - Cells, Cultured MH - Culture Media/metabolism MH - Diabetes Mellitus, Experimental/blood/chemically induced/*immunology MH - Humans MH - Inflammation Mediators/*metabolism MH - Lipopolysaccharides/immunology MH - Macrophages/*immunology/metabolism MH - Male MH - Mice MH - Primary Cell Culture MH - Signal Transduction/immunology MH - Toll-Like Receptor 4/immunology/*metabolism PMC - PMC6686006 COIS- The authors declare no competing interests. EDAT- 2019/08/09 06:00 MHDA- 2020/11/11 06:00 PMCR- 2019/08/07 CRDT- 2019/08/09 06:00 PHST- 2019/01/28 00:00 [received] PHST- 2019/07/25 00:00 [accepted] PHST- 2019/08/09 06:00 [entrez] PHST- 2019/08/09 06:00 [pubmed] PHST- 2020/11/11 06:00 [medline] PHST- 2019/08/07 00:00 [pmc-release] AID - 10.1038/s41598-019-47836-8 [pii] AID - 47836 [pii] AID - 10.1038/s41598-019-47836-8 [doi] PST - epublish SO - Sci Rep. 2019 Aug 7;9(1):11447. doi: 10.1038/s41598-019-47836-8.